| First Author | Shirakura K | Year | 2019 |
| Journal | J Cell Sci | Volume | 132 |
| Issue | 1 | PubMed ID | 30510113 |
| Mgi Jnum | J:269279 | Mgi Id | MGI:6273128 |
| Doi | 10.1242/jcs.220228 | Citation | Shirakura K, et al. (2019) The Robo4-TRAF7 complex suppresses endothelial hyperpermeability in inflammation. J Cell Sci 132(1):jcs220228 |
| abstractText | Roundabout guidance receptor 4 (Robo4) is an endothelial cell-specific receptor that stabilizes the vasculature in pathological angiogenesis. Although Robo4 has been shown to suppress vascular hyperpermeability induced by vascular endothelial growth factor (VEGF) in angiogenesis, the role of Robo4 in inflammation is poorly understood. In this study, we investigated the role of Robo4 in vascular hyperpermeability during inflammation. Endotoxemia models using Robo4 (-/-) mice showed increased mortality and vascular leakage. In endothelial cells, Robo4 suppressed tumor necrosis factor alpha (TNFalpha)-induced hyperpermeability by stabilizing VE-cadherin at cell junctions, and deletion assays revealed that the C-terminus of Robo4 was involved in this suppression. Through binding and localization assays, we demonstrated that in endothelial cells, Robo4 binds to TNF receptor-associated factor 7 (TRAF7) through interaction with the C-terminus of Robo4. Gain- and loss-of-function studies of TRAF7 with or without Robo4 expression showed that TRAF7 is required for Robo4-mediated suppression of hyperpermeability. Taken together, our results demonstrate that the Robo4-TRAF7 complex is a novel negative regulator of inflammatory hyperpermeability. We propose this complex as a potential future target for protection against inflammatory diseases. |
